SHE:002898 Revenue

Sailong Pharmaceutical Group had revenue of 64.31M CNY in the quarter ending September 30, 2025, with 2.60% growth. This brings the company's revenue in the last twelve months to 244.84M, down -19.46% year-over-year. In the year 2024, Sailong Pharmaceutical Group had annual revenue of 263.57M, down -15.15%.

Revenue (ttm)

244.84M

Revenue Growth

-19.46%

P/S Ratio

10.18

Revenue / Employee

476.35K

Employees

514

Market Cap

2.49B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	263.57M	-47.06M	-15.15%
Dec 31, 2023	310.63M	46.43M	17.58%
Jan 1, 2023	264.19M	17.11M	6.93%
Jan 1, 2022	247.08M	126.39M	104.73%
Dec 31, 2020	120.68M	-172.78M	-58.88%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shanghai Universal Biotech	1.07B
Shandong Sito Bio-technology	954.76M
Zhejiang East Asia Pharmaceutical	831.56M
Guiyang Xintian Pharmaceutical	755.34M
Jilin Jian Yisheng Pharmaceutical	639.10M
Hubei Goto Biopharm	626.28M
Jiangsu Sihuan Bioengineering	341.90M
Shanghai Serum Bio-Technology	196.76M

Revenue Rankings